A Total Artificial Heart (TAH), a breakthrough smart technology that could revolutionise how we treat heart failure. Unlike traditional heart devices, the TAH utilises advanced technologies such as magnetic levitation and artificial intelligence (AI) to replicate the natural blood flow of a healthy heart. This innovative approach not only aims to provide a viable alternative to heart transplants but also has the potential to improve the quality of life for patients in need of a heart replacement.
In November 2023, the company achieved a significant milestone when it received approval from the US Food and Drug Administration (FDA) to implant the TAH into a small number of patients. In 2024, the company received a $50 million grant from the Australian government’s Medical Research Future Fund to continue developing and commercialising the device.
【MORE】